Nothing Special   »   [go: up one dir, main page]

DE69722064D1 - 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate - Google Patents

1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate

Info

Publication number
DE69722064D1
DE69722064D1 DE69722064T DE69722064T DE69722064D1 DE 69722064 D1 DE69722064 D1 DE 69722064D1 DE 69722064 T DE69722064 T DE 69722064T DE 69722064 T DE69722064 T DE 69722064T DE 69722064 D1 DE69722064 D1 DE 69722064D1
Authority
DE
Germany
Prior art keywords
trisdehydro
dihydroxy
cholecalciferol derivatives
cholecalciferol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69722064T
Other languages
English (en)
Other versions
DE69722064T2 (de
Inventor
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69722064D1 publication Critical patent/DE69722064D1/de
Publication of DE69722064T2 publication Critical patent/DE69722064T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Liquid Crystal Substances (AREA)
DE69722064T 1996-03-21 1997-03-14 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate Expired - Fee Related DE69722064T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21
US13809 1996-03-21

Publications (2)

Publication Number Publication Date
DE69722064D1 true DE69722064D1 (de) 2003-06-26
DE69722064T2 DE69722064T2 (de) 2004-04-08

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722064T Expired - Fee Related DE69722064T2 (de) 1996-03-21 1997-03-14 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate

Country Status (30)

Country Link
EP (1) EP0796843B1 (de)
JP (1) JP2801587B2 (de)
KR (1) KR100240541B1 (de)
CN (1) CN1110477C (de)
AR (1) AR006315A1 (de)
AT (1) ATE240941T1 (de)
AU (1) AU708679B2 (de)
BR (1) BR9701404A (de)
CA (1) CA2199893C (de)
CO (1) CO4820396A1 (de)
CZ (1) CZ85897A3 (de)
DE (1) DE69722064T2 (de)
DK (1) DK0796843T3 (de)
ES (1) ES2198512T3 (de)
HR (1) HRP970162A2 (de)
HU (1) HUP9700609A3 (de)
ID (1) ID16285A (de)
IL (1) IL120469A0 (de)
MA (1) MA26423A1 (de)
MX (1) MX9702139A (de)
NO (1) NO971217L (de)
NZ (1) NZ314424A (de)
PE (1) PE42998A1 (de)
PL (1) PL319070A1 (de)
PT (1) PT796843E (de)
SG (1) SG70589A1 (de)
TR (1) TR199700219A2 (de)
TW (1) TW444001B (de)
YU (1) YU10397A (de)
ZA (1) ZA972302B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
EP0398217B1 (de) * 1989-05-18 1994-01-12 F. Hoffmann-La Roche Ag Dehydrocholecalciferolderivate

Also Published As

Publication number Publication date
DK0796843T3 (da) 2003-09-15
MX9702139A (es) 1998-04-30
HUP9700609A3 (en) 1999-03-01
AU708679B2 (en) 1999-08-12
ATE240941T1 (de) 2003-06-15
DE69722064T2 (de) 2004-04-08
ZA972302B (en) 1997-09-22
KR970065495A (ko) 1997-10-13
CO4820396A1 (es) 1999-07-28
SG70589A1 (en) 2000-02-22
BR9701404A (pt) 1998-11-03
CA2199893C (en) 2008-02-05
PE42998A1 (es) 1998-08-11
NO971217D0 (no) 1997-03-17
TW444001B (en) 2001-07-01
CA2199893A1 (en) 1997-09-21
NZ314424A (en) 1998-07-28
EP0796843B1 (de) 2003-05-21
CN1110477C (zh) 2003-06-04
MA26423A1 (fr) 2004-12-20
TR199700219A3 (tr) 1997-10-21
CN1172793A (zh) 1998-02-11
JPH107651A (ja) 1998-01-13
IL120469A0 (en) 1997-07-13
PL319070A1 (en) 1997-09-29
AU1513597A (en) 1997-09-25
PT796843E (pt) 2003-09-30
AR006315A1 (es) 1999-08-25
NO971217L (no) 1997-09-22
ID16285A (id) 1997-09-18
TR199700219A2 (xx) 1997-10-21
HU9700609D0 (en) 1997-05-28
JP2801587B2 (ja) 1998-09-21
HUP9700609A2 (hu) 1998-07-28
YU10397A (sh) 1999-07-28
EP0796843A2 (de) 1997-09-24
HRP970162A2 (en) 1998-04-30
KR100240541B1 (ko) 2000-01-15
ES2198512T3 (es) 2004-02-01
CZ85897A3 (cs) 1998-04-15
EP0796843A3 (de) 1999-04-14

Similar Documents

Publication Publication Date Title
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
TR28915A (tr) Naftokinon türevleri.
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
NO993024L (no) Polysakkarid-peptid-derivater
ATE199901T1 (de) 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700927A3 (tr) N-Benzilazolyum türevleri.
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOXELL S.P.A., MAILAND/MILANO, IT

8339 Ceased/non-payment of the annual fee